LncRNA TSLNC8 synergizes with EGFR inhibitor osimertinib to inhibit lung cancer tumorigenesis by blocking the EGFR-STAT3 pathway

.

Source: Cell Cycle - October 16, 2020 Category: Cytology Authors: Su-Zhen Zhou Han Li Zhi-Wan Wang Ming-Hang Wang Ning Li Yan-Fang Wang Source Type: research